Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) [Phase 3]

View source ↗

Summary

Phase 3 CHIPPI trial evaluating hyperthermic intraperitoneal chemotherapy for ovarian cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Ovary Neoplasms, Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING